The Regulators That Decide Merger Arbitrage: A Global Guide
Every merger arbitrage position eventually comes down to the same question: which regulator has to say yes, and how long will that actually take? This guide covers the major merger arbitrage regulators shaping spreads around the world — what each one reviews, how long it takes, and real examples of each in action.
A signed merger agreement is a starting gun, not a finish line. Before most deals can close, they need clearance from one or more competition authorities, and increasingly from foreign-investment or national-security regulators reviewing who ultimately owns and controls a business, separate from competition concerns.
The spread on a merger arb position is, in large part, a bet on how these processes unfold — not just whether they'll ultimately clear, but how long that takes and what conditions might get attached along the way.
The US runs three genuinely separate review tracks, and a single deal can face all three at once.
| Regulator | Reviews | Key Signal |
|---|---|---|
FTC / DOJ |
Antitrust — divides cases by industry | A Second Request adds 6–18+ months and signals a genuinely contested review |
CFIUS |
National security in foreign acquisitions | Confidential determinations; President holds ultimate block authority |
Industry regulators |
Insurance, banking, telecom, rail — layered on top of antitrust | State-by-state insurance approval can reopen even after being granted |
FTC and DOJ (antitrust). Nearly every US deal above a certain size has to file under the Hart-Scott-Rodino Act and clear an initial 30-day waiting period. A Second Request — a formal demand for extensive additional documents — reliably adds six months to well over a year, and its impact on spreads is immediate: this single event is the clearest signal that a deal has moved from routine to genuinely contested. The two agencies divide cases by industry, and enforcement posture shifts meaningfully with leadership changes at both.
CFIUS (foreign investment). A completely separate process from antitrust, focused on national security. CFIUS reviews foreign acquisitions of US businesses, with particular scrutiny on semiconductors, defense, critical infrastructure, and ports. Determinations are confidential and the President holds ultimate block authority. Even an indirect foreign-ownership angle — a sovereign wealth fund holding a stake in one of the acquiring parties, for instance — can trigger a CFIUS review timeline that runs independent of the deal's main antitrust track.
Industry-specific regulators. This is the track that trips up the most merger arb investors, because it's easy to assume "regulatory clearance" means antitrust clearance and stop there. Insurance, banking, telecom, utility, and transportation deals often need sign-off from specialized bodies layered on top of ordinary antitrust review — and because insurance regulation runs state-by-state, a deal can clear 51 of 52 required jurisdictions and still face a real, live gate in the one that hasn't signed off.
Real Example: State Regulators Can Reopen Their Own Approval
One recent deal cleared 51 of 52 required US jurisdictions, then the last state approved it too — only for a different state to suspend a previously-granted approval extension the same day, citing a need to "further review the transaction" given how much time had passed since it was first granted. Nothing about the deal's terms changed. The spread still moved sharply on the news.
Bank mergers need approval from banking regulators — the OCC, the Federal Reserve, and often state banking departments — on a separate track from antitrust. Railroad mergers go through the Surface Transportation Board, which runs one of the longest, most heavily litigated review processes of any US regulator, with proceedings that can stretch well over a year once formal review begins. Telecom and satellite deals need FCC approval for license transfers on top of standard clearance.
The European Commission's competition directorate reviews mergers meeting specific revenue thresholds under the EU Merger Regulation — broadly, combined worldwide revenue above roughly €5 billion and EU-specific revenue above roughly €250 million for each party, though the exact test has more nuance than that headline figure suggests. Review runs in two phases: an initial Phase I look, and — if the Commission has real concerns — a longer Phase II investigation that typically ends in either a conditioned clearance or, far less commonly, an outright prohibition. For arb purposes, the key signal is simply whether the Commission opens Phase II — that alone reliably adds months and marks a deal as genuinely contested.
The UK runs its own competition review independently of the EU post-Brexit, through the Competition and Markets Authority, plus a completely separate regime for takeovers of UK-listed companies.
CMA merger review. An initial Phase 1 look, escalating to a formal Phase 2 panel investigation if the CMA finds a realistic prospect of a substantial lessening of competition. The CMA has a reputation for particularly thorough scrutiny in technology and digital markets.
The Takeover Panel and City Code. A distinct, faster-moving process with real teeth: a mandatory bid triggers at roughly 30% ownership, an offer generally must complete or lapse within about 60 days, and 90% acceptance lets a bidder squeeze out remaining holders. The Panel is known for unusual speed and procedural discipline compared to most competition regulators.
China's State Administration for Market Regulation reviews deals meeting thresholds tied to combined worldwide and China-specific revenue, running through several sequential phases that frequently stretch a contested deal's timeline well beyond a year. SAMR technically allows for "silent approval" — a deal clears by default if no decision is issued within the review period — but in practice, silent approval is rare for contested deals with any US nexus, given how much broader geopolitical tension has made Chinese review outcomes less predictable in recent years.
Japan mirrors the US model of splitting antitrust and foreign-investment review. The JFTC handles antitrust and has historically been one of the more predictable, business-friendly regulators for domestic consolidation, with most reviews clearing at the initial phase. FEFTA handles foreign-investment review entirely separately, focused on national security in sensitive sectors including semiconductors, defense, and telecommunications.
| Regulator | Country | What Sets It Apart |
|---|---|---|
BKartA |
Germany | Expanded powers over large digital platforms; EU-threshold deals escalate to DG COMP |
AMF |
France | Mandatory bid threshold and compulsory squeeze-out, similar in spirit to the UK's regime |
ACCC |
Australia | Moved to mandatory pre-merger notification in 2024, a major shift from voluntary review |
ISED |
Canada | "Net benefit" review plus a separate national security screen for foreign acquisitions |
CADE |
Brazil | Mandatory notification with a fast-track option for limited overlap deals |
KFTC |
South Korea | Generally business-friendly, but real scrutiny on semiconductor and display-panel deals |
The abstractions above become concrete once you're actually tracking a live deal. A few patterns worth internalizing:
"All approvals obtained" doesn't always mean done. A deal can clear every jurisdiction in the world and still be stuck, if a single state-level regulator reopens a previously-granted approval, or if separate litigation — rather than the regulatory process itself — is the actual thing keeping the deal from closing.
Real Example: Clean Sweep, Real Obstacle
One large media merger cleared all 68 required jurisdictions worldwide — the EU, UK, China, and the US Department of Justice among them — with zero blocks anywhere. The acquirer's own statement put it plainly: the deal "could and would close today" but for an active antitrust lawsuit brought by a group of state attorneys general. Global regulatory risk hit zero, and the spread barely moved — the real gate was never regulatory to begin with.
Read what the merger agreement itself allows. The regulatory backdrop only tells you half the story. The other half is what the actual contract says a buyer is obligated to accept — some agreements include a negotiated "Burdensome Condition" carve-out that lets a buyer walk away from onerous regulatory demands rather than accept them, a fundamentally different risk profile than a deal where the buyer has no such contractual out.
Precedent matters, but isn't destiny. How a regulator has handled similar deals in the past is one of the most useful signals available — but posture shifts with leadership changes and political conditions, so precedent should inform a view, not replace one.
Multiple regulators rarely move in lockstep. It's common for a deal to sail through antitrust review in most of the world while facing a genuinely uncertain fight in exactly one jurisdiction — often the one with the most direct political or strategic stake in the outcome. A shipping merger requiring a foreign government's national-security-style approval, or a railroad merger under a uniquely slow domestic transportation regulator, can sit at a much wider spread than every other regulatory line item on the deal would suggest on its own.
ArbLens — Free Merger Arbitrage Tracker
ArbLens tracks the specific regulatory status, filings, and precedent behind every active deal we cover — not just whether a deal has "cleared," but what actually happened, what the underlying documents say, and what to watch next.
Readers across dozens of countries use ArbLens to track the deals that matter. Join them.
See live regulatory status, deal terms, and risk analysis across every active deal we track. Free, no account required.
Open ArbLens →Weekly deal briefings, spread analysis, and event-driven insights — delivered free every Friday.